| Date | Title | Description |
| 30.10.2024 | The Silent Threat: Bird Flu's Unseen Spread Among Humans | Bird flu, or highly pathogenic avian influenza (HPAI), is a silent predator lurking in the shadows of America’s dairy farms. As health departments scramble to track its spread, the challenges are mounting. Emails reveal a troubling picture:... |
| 29.10.2024 | Exclusive: Emails reveal how health departments struggle to track human cases of bird flu | The email tallied the people on farms in the state who were supposed to be monitored: “1250+ known workers plus an unknown amount exposed from dairies with whom we have not had contact or refused to provide information.”A July 29 email refl... |
| 22.07.2024 | CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine | Valneva to receive up to $41.3 million from CEPI and the European Union to expand access to chikungunya vaccine, IXCHIQ® Funding will support clinical trials in vulnerable groups, such as children and pregnant women Partnership will also su... |
| 22.07.2024 | CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine | Valneva to receive up to $41.3 million from CEPI and the European Union to expand access to chikungunya vaccine, IXCHIQ®Funding will support clinical trials in vulnerable groups, such as children and pregnant women Partnership will also sup... |
| 01.07.2024 | Scientists wary of bird flu pandemic 'unfolding in slow motion' | CHICAGO: Scientists tracking the spread of bird flu are increasingly concerned that gaps in surveillance may keep them several steps behind a new pandemic, according to Reuters interviews with more than a dozen leading disease experts.
Many... |
| 11.01.2023 | Another Ebola outbreak, another missed opportunity for preparedness | When I learned that an outbreak of Ebola was declared in Uganda last fall, I had a flashback to 2014 when I was working at Merck and an outbreak of Ebola disease caused by a different species of the virus emerged in full force in West Afric... |
| 30.11.2022 | Epidemic Coalition Task Force Aims to Develop Vaccine for 'Disease X' in 100 Days | April Fowell, Tech Times 30 November 2022, 03:11 pm
The Coalition for Epidemic Preparedness Innovations (CEPI) is tasked to develop a three times faster vaccine than the one developed for COVID. This is to protect against future pandemics, ... |
| 25.10.2022 | SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines | CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil. could be made available for late-stage development.
SK bioscience to secure new vaccines and establish pandemic respon... |
| 18.10.2022 | CEPI receives another 100 million euros BMBF funding | The German Federal Ministry of Education and Research (BMBF) will support the international initiative "Coalition for Epidemic Preparedness Innovations" (CEPI) with another 100 million euros to enable vaccine development against n... |
| 15.05.2022 | Bill Gates knows philanthropy alone can’t solve inequality | The WHO estimates that the Covid-19 pandemic has killed almost 15 million people worldwide — not just from the virus, but as an indirect result of the crisis, such as being unable to get other kinds of medical care because hospital systems ... |
| 25.02.2022 | Japan, UK pledge new funds to CEPI's $3.5B pandemic preparedness plan, with eye toward future outbreaks | As Covid-19 nears its inevitable, slow-to-develop endgame, the nations of the world are looking to speed the pandemic’s end while preparing for what comes next. A highly-touted plan from CEPI to turbocharge pandemic R&D has earned the f... |
| 02.02.2022 | Valneva : Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate - Form 6-K | Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate
CEPI-funded trial intended to support potential label expansion in this age group
Saint-Herblain(France), January 31, 2022 - Valneva ... |
| 17.11.2021 | With 128 Covid vaccines in clinical development, we don’t know if the approved/authorized ones are the best ones | Pfizer/BioNTech. Moderna. Johnson & Johnson. AstraZeneca.
These are the marquee names that spring to mind when you think of the vaccine companies at the forefront of the global fight against Covid-19. And for good reason: together they ... |
| 22.09.2021 | Clover's COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest | Trial enrolled over 30,000 adult & elderly participants across 4 continents; 100% of SARS-CoV-2 strains observed in efficacy analysis were variants (Delta was predominant strain)
Primary and secondary efficacy endpoints were successfull... |
| 23.07.2021 | Plague Inc. creators turned the Olympics into a superspreader event to help players understand the real risk of outbreaks at the games | ‘In Plague Inc, the Olympics has the potential to be a superspreader event for a disease outbreak,’ game creator James Vaughan told Insider. Plague Inc, Leon Neal/AFP via Getty Images
In the popular game Plague Inc. holding the Olympics dur... |
| 14.07.2021 | Scientists could create a single vaccine that fights multiple coronaviruses within 5 years, potentially preventing the next pandemic, an expert says | Woman receives COVID-19 vaccine. John Moore/Getty Images
Twenty groups of scientists are trying to create a single vaccine that fights multiple coronaviruses.
Coronavirus is the virus family that SARS-CoV-2 – which caused the COVID-19 pande... |
| 14.07.2021 | Scientists working on single multiple coronaviruses vaccine to fight future pandemics, expert says | Woman receives COVID-19 vaccine.
John Moore/Getty Images
Twenty groups of scientists are trying to create a single vaccine that fights multiple coronaviruses.
Coronavirus is the virus family that SARS-CoV-2 - which caused the Covid-19 pande... |
| 30.06.2021 | Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate | |
| 30.06.2021 | Dynavax Technologies : Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate | Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover's COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum)
Pending conditional regulatory approvals, Clover expects to commence product launch of SC... |
| 30.06.2021 | Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate | Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover's COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum)
Pending conditional regulatory approvals, Clover expects to commence product launch of SC... |
| 19.05.2021 | ZICCUM AB (PUBL)
ZICCUM : welcomes urgent calls to ramp up vaccine manufacturing across the globe to address inequity in vaccine access and prevent future pandemics | Last week saw repeated calls from influential global stakeholders to establish or upgrade vaccine manufacturing facilities, particularly those in low- and middle- income countries (LMICs). Ziccum CEO: “We welcome these important development... |
| 24.03.2021 | Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate | |
| 24.03.2021 | Clover Biopharmaceuticals : and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate | Over 22,000 participants aged 18 years or older are expected to be enrolled in SPECTRA across Latin America, Asia, Europe and Africa
Interim analysis of the primary endpoint expected in the middle of 2021
CHENGDU, China and EMERYVILLE, Cali... |
| 02.03.2021 | These Four Policy Changes Could Help Us Get Vaccines For The Next Pandemic Even Faster | President Biden and Governor Whitmer tour a Pfizer vaccine manufacturing facility. BRENDAN SMIALOWSKI/AFP via Getty Images |
| 26.02.2021 | Breaking Health Care's Four-Minute Mile | Co-Founder & CEO at Emedgene — on a mission to unlock genomic insights for the world’s health organizations with data-driven AI solutions. |
| 19.02.2021 | It Will Take The G-7 To Stop Covid-19: Here Are 5 Reasons Why | During today’s G-7 virtual meetings, President Joseph Biden announced the commencement of delivery on $4 Billion in Congressionally approved Covid-19 global aid. These meetings should be viewed as the best hope to begin a real discussion on... |
| 29.01.2021 | Gates Foundation backs gene therapy pioneers' second-gen Covid-19 vaccine | The Gates Foundation has backed another early-stage vaccine effort, handing up to $2.1 million to a pre-clinical candidate from a pair of gene therapy pioneers they think can offer benefits over the first wave of Covid-1... |
| 18.12.2020 | Leaders Need To Move Beyond Trusting Their Instincts | House Speaker Nancy Pelosi received a Pfizer-BioNTech COVID-19 vaccine in the U.S. Capitol Building ... [+] on December 18, 2020. (Photo by Anna Moneymaker-Pool/Getty Images)Getty Images |
| 07.12.2020 | How quickly can the US distribute a Covid-19 vaccine? Here are the four biggest logistical challenges. | The first shipments of Covid-19 vaccines could be just days away, as the Pfizer/BioNTech and Moderna shots await regulatory approval. Within 24 hours of the Food and Drug Administration’s go-ahead, either of these vaccines could begin shipp... |
| 08.07.2020 | Covid-19 roundup: Moderna sticks to July for its Phase III as rumors swirl; Following US lead, EU buys up Covid-19 treatments | The Phase III might be delayed from its original early July goal, but Moderna says it will still kick off the pivotal study for what could ultimately be the first Covid-19 vaccine before the end of the month.
A day after Reute... |
| 30.06.2020 | Science, policy and pandemics: Vaccines | Science, policy and pandemics: Vaccines
30-06-2020
What do we know about covid-19 vaccine candidates under development? What is involved in the vaccine development, trial and innovation process? How will a successful vaccine be distributed?... |
| 19.06.2020 | DYNAVAX TECHNOLOGIES CORPORATION
Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Clover Biopharmaceuticals' COVID-19 S-Trimer Vaccine Candidate with CpG 1018 Adjuvant | Preclinical results demonstrated the ability of CpG 1018-adjuvanted SCB-2019 to elicit neutralizing antibodies in multiple animal species
Clover expects to enroll 150 healthy adult and elderly participants in the Phase 1 study
Preliminary s... |
| 03.06.2020 | Create a health impact fund to spur development and equitable use of a Covid-19 vaccine | Calls for rethinking our pharmaceutical innovation system are swirling in the headwinds and tailwinds of Covid-19. How do we accelerate the arrival of treatments and vaccines in adequate quantities? And how do we ensure that everyone can ac... |
| 25.05.2020 | Билл Гейтс: что вам нужно знать о вакцине от Covid-19 | Инженер, бизнесмен и филантроп Билл Гейтс стал объектом атаки сторонников абсурдных теорий заговора о коронавирусе. В своём блоге Гейтс публикует обзоры, делится находками, рекомендует книги и выступления. Публикуем перевод статьи о гонке с... |
| 20.04.2020 | Government launches Vaccine Taskforce to combat coronavirus | A new Vaccine Taskforce will drive forward, expedite and co-ordinate efforts to research and then produce a coronavirus vaccine.
Rapid development and production of a coronavirus vaccine will be driven by a new government-led Vaccine Taskfo... |
| 20.04.2020 | Government launches Vaccine Taskforce to combat coronavirus | Government launches Vaccine Taskforce to combat coronavirus
20-04-2020
A new Vaccine Taskforce will drive forward, expedite and co-ordinate efforts to research and then produce a coronavirus vaccine.
Rapid development and production of a co... |
| 22.03.2020 | Билл Гейтс ответил на 31 вопрос о коронавирусе | Александра Кукуть Коронавирус 22 марта 2020, 15:00 Билл Гейтс ответил на 31 вопрос о коронавирусе
Сооснователь Microsoft Билл Гейтс не раз предупреждал о том, что мир не готов к пандемии. В марте этого года он покинул родную компанию, чтобы... |
| 18.03.2020 | Bill Gates addresses coronavirus fears and hopes in AMA | Bill Gates, newly free from his role on the Microsoft board, has taken to Reddit to answer the community’s questions about the pandemic, the government response, and what the world can do to be better prepared. Always candid but never cynic... |
| 25.02.2020 | In the race for coronavirus vaccines, don’t leave pregnant women behind | As several thousand people become newly infected each day with the novel coronavirus Covid-19, and some die of it, there are accelerated efforts to develop new coronavirus vaccines. The World Health Organization has activated its R&D Bl... |
| 24.02.2020 | A Chinese biotech partners with GSK to boost its coronavirus vaccine development | A Chinese biotech has taken up vaccine maker GSK’s offer to share its vaccine-boosting platform as it works to develop a product that can stop infection from the novel coronavirus, the companies announced Monday.
The company, Clover Biophar... |
| 18.02.2020 | Sanofi announces it will work with HHS to develop coronavirus vaccine | The drug maker Sanofi Pasteur is entering the race to develop a vaccine to protect against the new coronavirus sweeping through China, the company announced Monday.
David Loew, Sanofi’s global head of vaccines, said the company would partne... |
| 16.02.2020 | Could COVID-19 Spur A Revolution In Vaccine Development? | The daily reports out of Asia about COVID-19 (formerly the Wuhan Coronavirus) are driving a lot of fear of spreading contagion, and our hearts go out to the people of Hubei province and across China who are suffering terribly. But there is ... |
| 06.02.2020 | In effort to develop coronavirus vaccine, outbreak expert sees ‘hardest problem’ of his career | As China struggles to contain an epidemic caused by a new coronavirus, science is racing to develop vaccines to blunt the outbreak’s impact. Central to the effort is CEPI — the Oslo, Norway-based Coalition for Epidemic Preparedness Innovati... |
| 24.01.2020 | How fast can biotech come up with a vaccine for the latest outbreak? | The deadly outbreak of a novel coronavirus has sparked a race among biotech companies, each claiming that its technology can quickly whip up a vaccine to quell a potential crisis. But history suggests the road ahead will be long, unpredicta... |
| 04.01.2019 | ‘Neglected diseases’ are anything but neglected by the billion-plus people living with them | I dislike the term “neglected tropical diseases.” This collection of communicable diseases is neglected — a pejorative term — only by countries unaffected by them. They aren’t neglected by the 1 billion or more individuals afflicted with th... |
| 26.04.2017 | Fighting diphtheria: This old disease needs a new treatment | It’s a tragedy whenever a child dies needlessly of a disease that is both preventable and treatable. Sadly, that happens daily around the globe, due mainly to a raft of infectious diseases. One of these is diphtheria. It is still a killer m... |
| 13.12.2016 | Finding the world’s unknown viruses — before they find us | One by one, the viruses have slipped from their hiding places in nature to threaten global populations — SARS, MERS, Zika.
In each case, scientists have scrambled to identify the viruses and to develop vaccines or drugs to stop their spread... |
| - | Киберспорт: как индустрия не только пережила кризис, но и выросла | The Esports Reporter, NAVI, WePlay Esports и Maincast о том, как индустрия киберспорта адаптировалась, менялась и росла во время пандемии.
2 2 комментария
1236 просмотров
В марте 2020 года мир остановился: стадионы закрылись, фондовый рынок... |
| - | British agencies secure funds to develop standard monkeypox tools | British health agencies have secured $375,000 to develop tools for a standardised approach to test the performance of vaccines against monkeypox.
The Coalition for Epidemic Preparedness Innovations, which allocated the fundings, made the an... |
| - | WePlay! Esports спрямувала 3 млн грн на три апарати ШВЛ для лікарень України | WePlay! Esports спрямувала 3 млн грн на три апарати ШВЛ для лікарень України
01 апреля, 2020, 17:00
Новости компаний
2413
Нові апарати штучної вентиляції легень поїдуть у лікарні Хмельницького, Кропивницького та Києва. Засновники WePlay! Es... |
| - | Monkeypox is a dangerous disease threat — but has one key difference from Covid, epidemic coalition says | "This is the first time that we have gathered again in Davos since the 2020 meeting and we find ourselves facing another dangerous disease threat," CEPI CEO Richard Hatchett told CNBC's "Squawk Box Europe" at the World E... |
| - | The coronavirus at 1: A year into the pandemic, what scientists know about how it spreads, infects, and sickens | The coronavirus behind the pandemic presents some vexing dualities.
It’s dangerous enough that it dispatches patients to hospitals in droves and has killed more than 1.6 million people, but mild enough that most people shrug it off. It bloc... |
| - | We’ll meet again: Surviving the cancel culture of COVID-19 | The microscopic virus that causes COVID-19 has morphed once again into a shape-shifting monster in whose vast and deadly shadow nations seal their borders and global events are left hanging by a thread.
First came the coronavirus, then came... |
| - | WePlay! Esports вошла в список финалистов международной премии в области PR и коммуникаций от PR Daily | WePlay! Esports вошла в список финалистов международной премии в области PR и коммуникаций от PR Daily
07 Июля, 2020, 10:00
Новости компаний
1809
Коммуникационная кампания благотворительного киберспортивного онлайн-марафона WeSave! Charity ... |
